Sign-On Letter Demands That Pharmaceutical Companies Lower Cost Of AIDS Drugs
November 26, 1996
We realize that access to new and promising drugs and support for the programs that provide that access must remain at the center of our agenda. However, the astronomical prices of the new regimens makes that work more difficult. The Ad-Hoc Coalition for Drug Pricing developed the attached sign-on letter to demand that major pharmaceutical companies address these issues of cost. We invite you to join us and sign on to this letter by faxing the fax back sheet below by COB, December 5.
We, the undersigned organizations, demand that the pharmaceutical industry take the following steps to help end the crisis in access to life-saving prescription HIV/AIDS drugs:
The sad reality is that our fractured health care system is unable to bear the current cost of drugs. Limitations on access are everywhere, in both public and private insurance programs. These include impossibly low prescription drug caps, restricted formularies, unreasonably high prescription co-payments and burdensome prior authorization procedures. This cost squeeze is escalating, at a time when people with HIV and AIDS need access to more, and more costly, prescription drugs than ever - if they want to stay alive. It truly is an emergency. Hundreds of thousands of lives are at stake, and as a result, caring about questions of access must become standard business practice.
AIDS advocacy organizations will continue to fight for full access to prescription drugs. We have fought many successful battles against restrictive formularies. The success in securing increased ADAP funding was a result of the efforts of many in the community, in industry and in government and is a primary example of the advantage of working together.
The pharmaceutical industry has unique power to assist lowering drug prices, thus dramatically improving access to drugs. Price reductions are undeniably necessary. Without them, congressional hearings on this issue may be unavoidable.
We hope that the pharmaceutical industry will work with us to end the current drug access crisis.
Fax To Tonia Dickerson, Aids Action : (202) 986-1345
Please sign my organization, clinic, practice on to the drug pricing letter to be distributed to drug company executives.
** Deadline for sign-on, December 5, 1996 **
For more information, contact:
This article was provided by AIDS Action Council.